Pharmacovigilance is the set of activities aimed at continuously evaluating all information related to the safety of medicinal products, in order to ensure a favorable risk/benefit balance for the population.

Continuous monitoring of the safety profile of medicinal products is an integral part of protecting patients' health.

DOC chooses every day to protect public health by promoting the appropriate and safe use of our medicinal products

How to Report a Suspected Adverse Reaction

To report a suspected adverse reaction occurring following the use of a medicinal product, one of the following methods can be used:

• Contact the Pharmaceutical Company that is the Marketing Authorization Holder (MA) of the medicinal product. To report a suspected adverse reaction following the administration of DOC's medicinal products, please refer to the following contacts for the Pharmacovigilance department:
  • E-mail: farmacovigilanza@docpharma.com
  • Tel: +39 02 65534273
  • Fax: +39 02 65534275

• Contact the Local Pharmacovigilance Contact Point, following the instructions on the website of the Italian Health Authority (AIFA, Italian Medicines Agency)

• Fill in the online specific reporting form available at the following link.